Leptin, ghrelin, and endocannabinoids: Potential therapeutic targets in anorexia nervosa

Journal of Psychiatric Research

Volumn 43, Issue 7, 2009, Pages 671-679

  Støving, René Klinkby ^a   Andries, Alin ^a   Brixen, Kim ^a   Flyvbjerg, Allan ^b   Hørder, Kirsten ^a   Frystyk, Jan ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anorexia nervosa; Eating disorder; Endocannabinoids; Ghrelin; Leptin; Treatment

Indexed keywords

ANANDAMIDE; CANNABIS; ENDOCANNABINOID; GHRELIN; LEPTIN; NALOXONE; NOLADINE; RIMONABANT; UNCLASSIFIED DRUG;

ACUTE DISEASE; AMENORRHEA; ANOREXIA NERVOSA; ANXIETY DISORDER; BINGE EATING DISORDER; BODY WEIGHT; CACHEXIA; CHRONIC DISEASE; CLINICAL FEATURE; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG INHIBITION; DRUG POTENTIATION; DRUG TARGETING; FEEDING BEHAVIOR; FOOD INTAKE; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; LOW DRUG DOSE; MENSTRUAL CYCLE; NIGHTMARE; NONHUMAN; NUTRITIONAL STATUS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN INTERACTION; REFEEDING; RESTLESSNESS; REVIEW; SIGNAL TRANSDUCTION; STARVATION; SUICIDE ATTEMPT;

ANIMALS; ANOREXIA NERVOSA; ANXIETY; BODY WEIGHT; DEPRESSION; ENDOCANNABINOIDS; GHRELIN; HUMANS; LEPTIN; MENSTRUAL CYCLE;

EID: 62749170016     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2008.09.007     Document Type: Review

References (128)

1. Berry EM. Pilot study of THC (2,5 mg × 2) in 9 ambulatory AN patients (abstract). In: The sixth nordic congress on eating disorders, Aarhus, Denmark; 2006.
2. Agurell S., Halldin M., Lindgren J.E., Ohlsson A., Widman M., Gillespie H., et al. Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacological Reviews 38 (1986) 21-43
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). Washington, DC; 1994. p. 539-45.
4. Arendt M., Rosenberg R., Fjordback L., Brandholdt J., Foldager L., Sher L., et al. Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects. Psychological Medicine (2007) 1-11
5. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120 (2001) 337-345
6. Audi L., Mantzoros C.S., Vidal-Puig A., Vargas D., Gussinye M., and Carrascosa A. Leptin in relation to resumption of menses in women with anorexia nervosa. Molecular Psychiatry 3 (1998) 544-547
7. Avraham Y., Menachem A.B., Okun A., Zlotarav O., Abel N., Mechoulam R., et al. Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. Brain Research Bulletin 65 (2005) 117-123
8. Banks W.A. The blood-brain barrier as a regulatory interface in the gut-brain axes. Physiology and Behavior 89 (2006) 472-476
9. Beal J.E., Olson R., Laubenstein L., Morales J.O., Bellman P., Yangco B., et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. Journal of Pain and Symptom Management 10 (1995) 89-97
10. Bergh C., and Sodersten P. Anorexia nervosa, self-starvation and the reward of stress. Nature Medicine 2 (1996) 21-22
11. Brambilla F., Monteleone P., and Maj M. Olanzapine-induced weight gain in anorexia nervosa: involvement of leptin and ghrelin secretion?. Psychoneuroendocrinology 32 (2007) 402-406
12. Broglio F., Gianotti L., Destefanis S., Fassino S., Abbate D.G., Mondelli V., et al. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clinical Endocrinology (Oxford) 60 (2004) 592-599
13. Brooks E.R., Ogden B.W., and Cavalier D.S. Compromised bone density 11.4 years after diagnosis of anorexia nervosa. Journals of Womens Health 7 (1998) 567-574
14. Callahan H.S., Cummings D.E., Pepe M.S., Breen P.A., Matthys C.C., and Weigle D.S. Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. Journal of Clinical Endocrinology and Metabolism 89 (2004) 1319-1324
15. Casper R.C. The drive for activity and restlessness in anorexia nervosa: potential pathways. Journal of Affective Disorders 92 (2006) 99-107
16. Chan J.L., and Mantzoros C.S. Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhea and anorexia nervosa. Lancet 366 (2005) 74-85
17. Chan J.L., Heist K., DePaoli A.M., Veldhuis J.D., and Mantzoros C.S. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. Journal of Clinical Investigation 111 (2003) 1409-1421
18. Clement K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392 (1998) 398-401
19. Cota D., Marsicano G., Lutz B., Vicennati V., Stalla G.K., Pasquali R., et al. Endogenous cannabinoid system as a modulator of food intake. International Journal of Obesity and Related Metabolic Disorders 27 (2003) 289-301
20. Cota D., Marsicano G., Tschop M., Grubler Y., Flachskamm C., Schubert M., et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. Journal of Clinical Investigation 112 (2003) 423-431
21. Couturier J., and Lock J. What is remission in adolescent anorexia nervosa? A review of various conceptualizations and quantitative analysis. International Journal of Eating Disorders 39 (2006) 175-183
22. Cummings D.E., Clement K., Purnell J.Q., Vaisse C., Foster K.E., Frayo R.S., et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nature Medicine 8 (2002) 643-644
23. Dardennes R.M., Zizzari P., Tolle V., Foulon C., Kipman A., Romo L., et al. Family trios analysis of common polymorphisms in the obestatin/ghrelin, BDNF and AGRP genes in patients with anorexia nervosa: association with subtype, body-mass index, severity and age of onset. Psychoneuroendocrinology 32 (2007) 106-113
24. De Souza M.J., Leidy H.J., O'Donnell E., Lasley B., and Williams N.I. Fasting ghrelin levels in physically active women: relationship with menstrual disturbances and metabolic hormones. Journal of Clinical Endocrinology and Metabolism 89 (2004) 3536-3542
25. Denson T.F., and Earleywine M. Decreased depression in marijuana users. Addictive Behaviors 31 (2006) 738-742
26. Di M.V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410 (2001) 822-825
27. Dumas P., Saoud M., Bouafia S., Gutknecht C., Ecochard R., Dalery J., et al. Cannabis use correlates with schizotypal personality traits in healthy students. Journal of Psychiatric Research 109 (2002) 27-35
28. Ealey K.N., Fonseca D., Archer M.C., and Ward W.E. Bone abnormalities in adolescent leptin-deficient mice. Regulatory Peptides 136 (2006) 9-13
29. Elburg A.A., Eijkemans M.J., Kas M.J., Themmen A.P., de Jong F.H., van Engeland H., et al. Predictors of recovery of ovarian function during weight gain in anorexia nervosa. Fertility and Sterility 87 4 (2007) 902-908
30. Elmquist J.K., Bjorbaek C., Ahima R.S., Flier J.S., and Saper C.B. Distributions of leptin receptor mRNA isoforms in the rat brain. Journal of Comparative Neurology 395 (1998) 535-547
31. Erdmann J., Topsch R., Lippl F., Gussmann P., and Schusdziarra V. Postprandial response of plasma ghrelin levels to various test meals in relation to food intake, plasma insulin, and glucose. Journal of Clinical Endocrinology and Metabolism 89 (2004) 3048-3054
32. Esel E., Ozsoy S., Tutus A., Sofuoglu S., Kartalci S., Bayram F., et al. Effects of antidepressant treatment and of gender on serum leptin levels in patients with major depression. Progress in Neuro Psychopharmacology and Biological Psychiatry 29 (2005) 565-570
33. Exner C., Hebebrand J., Remschmidt H., Wewetzer C., Ziegler A., Herpertz S., et al. Leptin suppresses semi-starvation induced hyperactivity in rats: implications for anorexia nervosa. Molecular Psychiatry 5 (2000) 476-481
34. Fergusson D.M., Horwood L.J., and Ridder E.M. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 100 (2005) 354-366
35. Foltin R.W., Fischman M.W., and Byrne M.F. Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite 11 (1988) 1-14
36. Fride E. The endocannabinoid-CB(1) receptor system in pre- and postnatal life. European Journal of Pharmacology 500 (2004) 289-297
37. Fride E., Bregman T., and Kirkham T.C. Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood. Experimental Biology and Medicine (Maywood) 230 (2005) 225-234
38. Fukushima N., Hanada R., Teranishi H., Fukue Y., Tachibana T., Ishikawa H., et al. Ghrelin directly regulates bone formation. Journal of Bone and Mineral Research 20 (2005) 790-798
39. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. In: Proceedings of the National Academy of Sciences (USA), vol. 102; 2005. p. 18620-25.
40. Golden N.H., and Meyer W. Nutritional rehabilitation of anorexia nervosa. Goals and dangers. International Journal of Adolescens Medicine and Health 16 (2004) 131-144
41. Gorwood P., Kipman A., and Foulon C. The human genetics of anorexia nervosa. European Journal of Pharmacology 480 (2003) 163-170
42. Grinspoon L., and Bakalar J.B. The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research. Journal of Psychoactive Drugs 30 (1998) 171-177
43. Grinspoon S., Gulick T., Askari H., Landt M., Lee K., Anderson E., et al. Serum leptin levels in women with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 81 (1996) 3861-3863
44. Grinspoon S., Thomas L., Miller K., Herzog D., and Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 87 (2002) 2883-2891
45. Gross H., Ebert M.H., Faden V.B., Goldberg S.C., Kaye W.H., Caine E.D., et al. A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa. Journal of Clinical Psychopharmacology 3 (1983) 165-171
46. Haas V., Onur S., Paul T., Nutzinger D.O., Bosy-Westphal A., Hauer M., et al. Leptin and body weight regulation in patients with anorexia nervosa before and during weight recovery. American Journal of Clinical Nutrition 81 (2005) 889-896
47. Hao S., Avraham Y., Mechoulam R., and Berry E.M. Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. European Journal of Pharmacology 392 (2000) 147-156
48. Harrold J.A., and Williams G. The cannabinoid system: a role in both the homeostatic and hedonic control of eating?. British Journal of Nutrition 90 (2003) 729-734
49. Hebebrand J., Blum W.F., Barth N., Coners H., Englaro P., Juul A., et al. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Molecular Psychiatry 2 (1997) 330-334
50. Holtkamp K., Hebebrand J., Mika C., Grzella I., Heer M., Heussen N., et al. The effect of therapeutically induced weight gain on plasma leptin levels in patients with anorexia nervosa. Journal of Psychiatric Research 37 (2003) 165-169
51. Holtkamp K., Herpertz-Dahlmann B., Hebebrand K., Mika C., Kratzsch J., and Hebebrand J. Physical activity and restlessness correlate with leptin levels in patients with adolescent anorexia nervosa. Biological Psychiatry 60 (2006) 311-313
52. Hotta M., Ohwada R., Katakami H., Shibasaki T., Hizuka N., and Takano K. Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 89 (2004) 5707-5712
53. Iqbal J., Kurose Y., Canny B., and Clarke I.J. Effects of central infusion of ghrelin on food intake and plasma levels of growth hormone, luteinizing hormone, prolactin, and cortisol secretion in sheep. Endocrinology 147 (2006) 510-519
54. Janas-Kozik M., Mazurek U., Krupka-Matuszczyk I., Stachowicz M., Glogowska-Ligus J., and Wilczok T. The transcript expression profile of the leptin receptor-coding gene assayed with the oligonucleotide microarray technique - could this be an anorexia nervosa marker?. Cellular and Molecular Biology Letters 11 (2006) 62-69
55. Karsenty G. Leptin controls bone formation through a hypothalamic relay. Recent Progress in Hormone Research 56 (2001) 401-415
56. Kaye W.H., Nagata T., Weltzin T.E., Hsu L.K., Sokol M.S., McConaha C., et al. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biological Psychiatry 49 (2001) 644-652
57. Kelesidis T., and Mantzoros C.S. The emerging role of leptin in humans. Pediatric Endocrinology Reviews 3 (2006) 239-248
58. Kratzsch J., Lammert A., Bottner A., Seidel B., Mueller G., Thiery J., et al. Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence. Journal of Clinical Endocrinology and Metabolism 87 (2002) 4587-4594
59. Laessle R.G., Schweiger U., and Pirke K.M. Depression as a correlate of starvation in patients with eating disorders. Biological Psychiatry 23 (1988) 719-725
60. Laughlin G.A., and Yen S.S. Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea. Journal of Clinical Endocrinology and Metabolism 82 (1997) 318-321
61. Licinio J., Mantzoros C., Negrao A.B., Cizza G., Wong M.L., Bongiorno P.B., et al. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nature Medicine 3 (1997) 575-579
62. Lob S., Pickel J., Bidlingmaier M., Schaaf L., Backmund H., Gerlinghoff M., et al. Serum leptin monitoring in anorectic patients during refeeding therapy. Experimental Clinical Endocrinology Diabetes 111 (2003) 278-282
63. Lowe B., Zipfel S., Buchholz C., Dupont Y., Reas D.L., and Herzog W. Long-term outcome of anorexia nervosa in a prospective 21-year follow-up study. Psychological Medicine 31 (2001) 881-890
64. Lu XY, Kim CS, Frazer A, Zhang W. Leptin: a potential novel antidepressant. In: Proceedings of the National Academy of Sciences (USA), vol. 103; 2006. p. 1593-8.
65. Makovey J., Naganathan V., Seibel M., and Sambrook P. Gender differences in plasma ghrelin and its relations to body composition and bone - an opposite-sex twin study. Clinical Endocrinology (Oxford) 66 (2007) 530-537
66. Manara F., Manara A., and Todisco P. Correlation between psychometric and biological parameters in anorexic and bulimic patients during and after an intensive day hospital treatment. Eating and Weight Disorders 10 4 (2005) 236-244
67. Mantzoros C., Flier J.S., Lesem M.D., Brewerton T.D., and Jimerson D.C. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. Journal of Clinical Endocrinology and Metabolism 82 (1997) 1845-1851
68. Maor G., Rochwerger M., Segev Y., and Phillip M. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. Journal of Bone and Mineral Research 17 (2002) 1034-1043
69. Mehler P.S. Osteoporosis in anorexia nervosa: prevention and treatment. International Journal of Eating Disorders 33 (2003) 113-126
70. Miljic D., Pekic S., Djurovic M., Doknic M., Milic N., Casanueva F.F., et al. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 91 (2006) 1491-1495
71. Minocci A., Savia G., Lucantoni R., Berselli M.E., Tagliaferri M., Calo G., et al. Leptin plasma concentrations are dependent on body fat distribution in obese patients. International Journal of Obesity and Related Metabolic Disorders 24 (2000) 1139-1144
72. Misra M., Miller K.K., Almazan C., Ramaswamy K., Aggarwal A., Herzog D.B., et al. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 89 (2004) 3486-3495
73. Misra M., Miller K.K., Herzog D.B., Ramaswamy K., Aggarwal A., Almazan C., et al. Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. Journal of Clinical Endocrinology and Metabolism 89 (2004) 1605-1612
74. Misra M., Miller K.K., Stewart V., Hunter E., Kuo K., Herzog D.B., et al. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. Journal of Clinical Endocrinology and Metabolism 90 (2005) 5082-5087
75. Montague C.T., Farooqi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J., et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387 (1997) 903-908
76. Monteleone P., Di Lieto A., Tortorella A., Longobardi N., and Maj M. Circulating leptin in patients with anorexia nervosa, bulimia nervosa or binge-eating disorder: relationship to body weight, eating patterns, psychopathology and endocrine changes. Psychiatry Research 94 2 (2000) 121-129
77. Monteleone P., Matias I., Martiadis V., De P.L., Maj M., and Di M.V. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 30 (2005) 1216-1221
78. Nagaya N., Uematsu M., Kojima M., Date Y., Nakazato M., Okumura H., et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 104 (2001) 2034-2038
79. Nakai Y., Hosoda H., Nin K., Ooya C., Hayashi H., Akamizu T., et al. Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa. European Journal of Endocrinology 149 (2003) R1-R3
80. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
81. Naruse T., Amano H., and Koizumi Y. Possible involvement of dopamine D-1 and D-2 receptors in diazepam-induced hyperphagia in rats. Fundamental Clinical Pharmacology 5 (1991) 677-693
82. Nedvidkova J., Krykorkova I., Bartak V., Papezova H., Gold P.W., Alesci S., et al. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 88 (2003) 1678-1682
83. Nelson K., Walsh D., Deeter P., and Sheehan F. A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. Journal of Palliative Care 10 (1994) 14-18
84. Nordentoft M. Ugeskraeft for Laeger 168 (2006) 3896-3898 [Cannabis and psychosis]
85. Otto B., Cuntz U., Fruehauf E., Wawarta R., Folwaczny C., Riepl R.L., et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. European Journal of Endocrinology 145 (2001) 669-673
86. Otto B., Tschop M., Fruhauf E., Heldwein W., Fichter M., Otto C., et al. Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroendocrinology 30 (2005) 577-581
87. Piomelli D., Tarzia G., Duranti A., Tontini A., Mor M., Compton T.R., et al. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Reviews 12 (2006) 21-38
88. Pirke K.M., Broocks A., Wilckens T., Marquard R., and Schweiger U. Starvation-induced hyperactivity in the rat: the role of endocrine and neurotransmitter changes. Neurosciences Biobehavior Reviews 17 (1993) 287-294
89. Pollice C., Kaye W.H., Greeno C.G., and Weltzin T.E. Relationship of depression, anxiety, and obsessionality to state of illness in anorexia nervosa. International Journal of Eating Disorders 21 (1997) 367-376
90. Pomerants T., Tillmann V., Jurimae J., and Jurimae T. The influence of serum ghrelin, IGF axis and testosterone on bone mineral density in boys at different stages of sexual maturity. Journal of Bone and Mineral Metabolism 25 (2007) 193-197
91. Powers P.S., and Santana C. Available pharmacological treatments for anorexia nervosa. Expert Opinion on Pharmacotherapy 5 (2004) 2287-2292
92. Prentice A.M., Moore S.E., Collinson A.C., and O'Connell M.A. Leptin and undernutrition. Nutrition Reviews 60 (2002) S56-S67
93. Cannabis and cannabis-based medicines - potential benefits and risks to health. In: 2005. Rimonabant: new drug. Obesity: loss of a few kilos, many questions. Prescrire International, vol. 15; 2006. p. 123-6.
94. Rosenbaum M., Nicolson M., Hirsch J., Heymsfield S.B., Gallagher D., Chu F., et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. Journal of Clinical Endocrinology and Metabolism 81 (1996) 3424-3427
95. Schneider L.F., and Warren M.P. Functional hypothalamic amenorrhea is associated with elevated ghrelin and disordered eating. Fertility and Sterility 86 (2006) 1744-1749
96. Shimizu Y., Nagaya N., Isobe T., Imazu M., Okumura H., Hosoda H., et al. Increased plasma ghrelin level in lung cancer cachexia. Clinical Cancer Research 9 (2003) 774-778
97. Siegfried Z., Kanyas K., Latzer Y., Karni O., Bloch M., Lerer B., et al. Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetic 125 (2004) 126-130
98. Steppan C.M., Crawford D.T., Chidsey-Frink K.L., Ke H., and Swick A.G. Leptin is a potent stimulator of bone growth in ob/ob mice. Regulatory Peptides 92 (2000) 73-78
99. Stevenson J.C. Justification for the use of HRT in the long-term prevention of osteoporosis. Maturitas 51 (2005) 113-126
100. Stock S., Leichner P., Wong A.C., Ghatei M.A., Kieffer T.J., Bloom S.R., et al. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. Journal of Clinical Endocrinology and Metabolism 90 (2005) 2161-2168
101. Stoving R.K., Vinten J., Handberg A., Ebbesen E.N., Hangaard J., Hansen-Nord M., et al. Diurnal variation of the serum leptin concentration in patients with anorexia nervosa. Clinical Endocrinology (Oxford) 48 (1998) 761-768
102. Stoving R.K., Hangaard J., and Hagen C. Update on endocrine disturbances in anorexia nervosa. Journal of Pediatric Endocrinoly and Metabolism 14 (2001) 459-480
103. Stoving R.K., Chen J.W., Glintborg D., Brixen K., Flyvbjerg A., Horder K., et al. Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 92 (2007) 2323-2329
104. Strasser F., Luftner D., Possinger K., Ernst G., Ruhstaller T., Meissner W., et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-in-Cachexia-Study-Group. Journal of Clinical Oncology 24 (2006) 3394-3400
105. Strokosch G.R., Friedman A.J., Wu S.C., and Kamin M. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. Journal of Adolescens Health 39 (2006) 819-827
106. Swift W., Gates P., and Dillon P. Survey of Australians using cannabis for medical purposes. Harm Reduction Journal 2 (2005) 18
107. Takala J., Ruokonen E., Webster N.R., Nielsen M.S., Zandstra D.F., Vundelinckx G., et al. Increased mortality associated with growth hormone treatment in critically ill adults. New England Journal of Medicine 341 (1999) 785-792
108. Tanaka M., Naruo T., Muranaga T., Yasuhara D., Shiiya T., Nakazato M., et al. Increased fasting plasma ghrelin levels in patients with bulimia nervosa. European Journal of Endocrinology 146 (2002) R1-R3
109. Tanaka M., Naruo T., Nagai N., Kuroki N., Shiiya T., Nakazato M., et al. Habitual binge/purge behavior influences circulating ghrelin levels in eating disorders. Journal of Psychiatric Research 37 (2003) 17-22
110. Tanaka M., Naruo T., Yasuhara D., Tatebe Y., Nagai N., Shiiya T., et al. Fasting plasma ghrelin levels in subtypes of anorexia nervosa. Psychoneuroendocrinology 28 (2003) 829-835
111. Tanaka M., Tatebe Y., Nakahara T., Yasuhara D., Sagiyama K., Muranaga T., et al. Eating pattern and the effect of oral glucose on ghrelin and insulin secretion in patients with anorexia nervosa. Clinical Endocrinology (Oxford) 59 (2003) 574-579
112. Tanaka M., Nakahara T., Kojima S., Nakano T., Muranaga T., Nagai N., et al. Effect of nutritional rehabilitation on circulating ghrelin and growth hormone levels in patients with anorexia nervosa. Regulatory Peptides 122 (2004) 163-168
113. Tartaglia L.A. The leptin receptor. Journal of Biological Chemistry 272 (1997) 6093-6096
114. Thomas T., Gori F., Khosla S., Jensen M.D., Burguera B., and Riggs B.L. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140 (1999) 1630-1638
115. Thornton J.E., Cheung C.C., Clifton D.K., and Steiner R.A. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138 (1997) 5063-5066
116. Torstveit M.K., and Sundgot-Borgen J. The female athlete triad: are elite athletes at increased risk?. Medicine and Science in Sports and Exercise 37 (2005) 184-193
117. Tozzi F., Thornton L.M., Klump K.L., Fichter M.M., Halmi K.A., Kaplan A.S., et al. Symptom fluctuation in eating disorders: correlates of diagnostic crossover. American Journal of Psychiatry 162 (2005) 732-740
118. Troisi A., Di Lorenzo G., Lega I., Tesauro M., Bertoli A., Leo R., et al. A Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: relations with eating patterns and circulating concentrations of cortisol and thyroid hormones. Neuroendocrinology 81 (2005) 259-266
119. Vestergaard P., Emborg C., Stoving R.K., Hagen C., Mosekilde L., and Brixen K. Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders - a nationwide register study. International Journal of Eating Disorders 32 (2002) 301-308
120. Viveros M.P., Marco E.M., Llorente R., and Lopez-Gallardo M. Endocannabinoid system and synaptic plasticity: implications for emotional responses. Neural Plasticity (2007) 52908
121. Vulliemoz N.R., Xiao E., Xia-Zhang L., Germond M., Rivier J., and Ferin M. Decrease in luteinizing hormone pulse frequency during a five-hour peripheral ghrelin infusion in the ovariectomized rhesus monkey. Journal of Clinical Endocrinology and Metabolism 89 (2004) 5718-5723
122. Walsh B.T., Kaplan A.S., Attia E., Olmsted M., Parides M., Carter J.C., et al. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. Journal of American Medical Association 295 (2006) 2605-2612
123. Welch S.P., and Eads M. Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Research 848 (1999) 183-190
124. Welt C.K., Chan J.L., Bullen J., Murphy R., Smith P., DePaoli A.M., et al. Recombinant human leptin in women with hypothalamic amenorrhea. New England Journal of Medicine 351 (2004) 987-997
125. Wong M.L., Licinio J., Yildiz B.O., Mantzoros C.S., Prolo P., Kling M., et al. Simultaneous and continuous 24-hour plasma and cerebrospinal fluid leptin measurements: dissociation of concentrations in central and peripheral compartments. Journal of Clinical Endocrinology and Metabolism 89 (2004) 258-265
126. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., et al. Ghrelin enhances appetite and increases food intake in humans. Journal of Clinical Endocrinology and Metabolism 86 (2001) 92
127. Yoshimoto A., Mori K., Sugawara A., Mukoyama M., Yahata K., Suganami T., et al. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. Journal of American Society of Nephrology 13 (2002) 2748-2752
128. Zastrow O., Seidel B., Kiess W., Thiery J., Keller E., Bottner A., et al. The soluble leptin receptor is crucial for leptin action: evidence from clinical and experimental data. International Journal of Obesity and Related Metabolic Disorders 27 (2003) 1472-1478